• 1
    Bonow RO., Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008;52:e1142.
  • 2
    Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. American College of Chest P. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133 (6 Suppl):844S86S.
  • 3
    Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160:1916.
  • 4
    Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 2004;92:74751.
  • 5
    James AH, Brancazio LR, Gehrig TR, Wang A, Ortel TL. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J Matern Fetal Neonatal Med 2006;19:5439.
  • 6
    HIP-CAT study. Data on file. Aventis Pharmaceuticals.
  • 7
    Arnaout MS, Kazma H, Khalil A, Shasha N, Nasrallah A, Karam K, et al. Is there a safe anticoagulation protocol for pregnant women with prosthetic valves? Clin Exp Obstet Gynecol 1998;25:1014.
  • 8
    Izaguirre R, De La Pena A, Ramirez A, Cortina E, Huerta M, Salazar E. Anti-Xa activity with low-molecular-weight heparin, enoxaparin, during pregnancy in women with mechanical heart valves. Proc West Pharmacol Soc 2002;45:1278.
  • 9
    Lee LH. Low molecular weight heparin (LMWH) for thromboprophylaxis during pregnanciy in patients with mechanical heart valves. Blood 2000;96:97b.
  • 10
    Lindhoff-Last E, Schinzel H, Erbe M, Schachinger V, Bauersachs R. [Anticoagulation of pregnant women with mechanical heart valve prostheses]. Z Kardiol 2001;90 (Suppl 6):12530.
  • 11
    Meschengieser SS, Salviu MJ, Sanchez Luceros A, Casais P, Hendler M, Turdo K, et al. Low molecular weight heparin (LMWH) in pregnant women with mechanical prosthetic heart valves. J Thromb Haemost 2003;1 (Suppl 1):P1479.
  • 12
    Rowan JA, McCowan LM, Raudkivi PJ, North RA. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001;185:6337.
  • 13
    Vural KM, Ozatik MA, Uncu H, Emir M, Yurdagok O, Sener E, et al. Pregnancy after mechanical mitral valve replacement. J Heart Valve Dis 2003;12:3706.
  • 14
    McCowan LME, Harding JE, Stewart AW. Customized birthweight centiles predict SGA pregnancies with perinatal morbidity. BJOG 2005;112:102633.
  • 15
    Van Driel D, Wesseling J, Sauer PJJ, Touwen BCL, van der Beer E, Heymans HSA. Teratogen update: fetal effects ofter in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology 2002;66:12740.
  • 16
    Elkayam U, Bitar F. Valvular heart disease and pregnancy. Part II: prosthetic valves. J Am Coll Cardiol 2005;46:40310.
  • 17
    Abildgaard U, Sandset PM, Hammerstrom J, Gjestvang FT, Tviet A. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin. Thromb Res 2009;124:2627.
  • 18
    Turpie AGG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1994;329:5249.
  • 19
    Verstraete M. Pharmacotherapeutic aspects of unfractionated heparin and low molecular weight heparins. Drugs 1990;40:498530.
  • 20
    Lecuru F, Desnos M, Taurelle R. Anticoagulant therapy in pregnancy. Report of 54 cases. Acta Obstet Gynecol Scand 1996;75:21721.
  • 21
    Cotrufo M, De Feo M, De Santo LS, Romano G, Della Corte A, Renzulli A, et al. Risk of warfarin during pregnancy with mechanical valve prostheses. Obstet Gynecol 2002;99:3540.